Skip to content

Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)

Optima CAD (Optimal Mechanical Evaluation)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00896142
Enrollment
50
Registered
2009-05-11
Start date
2006-10-31
Completion date
Unknown
Last updated
2011-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Ischemic Cardiomyopathy

Keywords

ischemic cardiomyopathy, cardiac resynchronization therapy, LV structure and function

Brief summary

To evaluate the impact of left ventricular (LV) lead location on LV mechanical function.

Interventions

None listed

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Ischemic Cardiomyopathy 2. Left ventricular ejection fraction less than 40% 3. Clinical indication for invasive electrophysiology testing 4. Patient is at least 18 years of age

Exclusion criteria

1. Unstable angina, acute myocardial infarction and/or revascularization procedure within 3 months 2. CVA or TIA within the past 6 months 3. Prosthetic heart valve 4. Patient is status post heart transplant 5. Women who are pregnant or with child -bearing potential and who are not on a reliable form of birth control. Women of child-bearing potential are routinely tested for pregnancy as part of the standard of care prior to EPS procedures being performed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026